Aspect Biosystems Raises $20 Million in Series A Funding

Aspect Biosystems, a biotechnology company pioneering microfluidic 3D bioprinting of human tissues, has raised $20 million in a Series A funding round, the startup announced. The Canadian based biotech startup is led by Egyptian-Canadian entrepreneur...